<SEC-DOCUMENT>0001485003-23-000092-index.html : 20230228 <SEC-HEADER>0001485003-23-000092.hdr.sgml : 20230228 <ACCEPTANCE-DATETIME>20230228080731 ACCESSION NUMBER: 0001485003-23-000092 CONFORMED SUBMISSION TYPE: 425 PUBLIC DOCUMENT COUNT: 11 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 425 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 23678522 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 425 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 </SEC-HEADER> <DOCUMENT> <TYPE>425 <SEQUENCE>1 <FILENAME>sesnformfy2022earningsrele.htm <DESCRIPTION>425 <TEXT> Document 1 - file: sesnformfy2022earningsrele.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>a20230228_4q2022earnings.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: a20230228_4q2022earnings.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>a20230228_4q2022earnings001.jpg <TEXT> Document 3 - file: a20230228_4q2022earnings001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>a20230228_4q2022earnings002.jpg <TEXT> Document 4 - file: a20230228_4q2022earnings002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>a20230228_4q2022earnings003.jpg <TEXT> Document 5 - file: a20230228_4q2022earnings003.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>a20230228_4q2022earnings004.jpg <TEXT> Document 6 - file: a20230228_4q2022earnings004.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>a20230228_4q2022earnings005.jpg <TEXT> Document 7 - file: a20230228_4q2022earnings005.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>a20230228_4q2022earnings006.jpg <TEXT> Document 8 - file: a20230228_4q2022earnings006.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>a20230228_4q2022earnings007.jpg <TEXT> Document 9 - file: a20230228_4q2022earnings007.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>a20230228_4q2022earnings008.jpg <TEXT> Document 10 - file: a20230228_4q2022earnings008.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>a20230228_4q2022earnings009.jpg <TEXT> Document 11 - file: a20230228_4q2022earnings009.jpg
</DOCUMENT> </SEC-DOCUMENT>